NIAID announces new COVID-19 priorities The U.S. National Institute of Allergy and Infectious Diseases (NIAID) has released a new strategic plan for accelerating research to diagnose, prevent, and treat COVID-19.
New COVID-19 R&D initiatives announced A series of new initiatives aims to simplify scientific literature discovery and acquisition during the COVID-19 crisis, according to Research Solutions. These products include the launch of the COVID-19 Research Viewer Gadget.
Directed evolution shows promise in reducing drug discovery times A research collaboration between scientists at the University of Leeds and AstraZeneca resulted in the development of a technique that can significantly reduce the discovery time for possible new antibody-based therapies. The approach, published in Nature Communications on April 14, shows how protein fragments can be screened for susceptibility to aggregation in early drug discovery. Discuss